
Professor Jane Armitage
University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
Membership:
FESC Member
Follow
Biography
Jane Armitage is Professor of Clinical Trials and Epidemiology in the Nuffield Department of Population Health (NDPH) at the University of Oxford and Honorary Consultant in Public Health Medicine at the Oxford University Hospital. She joined the Clinical Trial Service Unit, now part of NDPH, in 1990 from a background in clinical medicine, with particular experience in respiratory medicine, geriatrics and diabetes. She has co-ordinated a series of large-scale randomised trials including the MRC/BHF Heart Protection Study, SEARCH and HPS2-THRIVE, which are trials of lipid modification in people with or at risk of vascular disease, as well as the ASCEND trial of aspirin and fish oils in diabetes. Her main research interests are in lipids and the epidemiology of cardiovascular and other chronic disease. She is Course Director for the Oxford University Master’s in Clinical Trials starting in 2020.
Contributor content
Session
Secondary prevention: biomarkers to optimise outcomes
31 August 2025
Session
Global health trends (2)
30 August 2025
Session
Young Investigator Award Session in Population Science, Genetics, and Epidemiology
30 August 2025
Session
Ask the Trialist - ABYSS
30 August 2024
Session
How to manage patients with high LDL cholesterol
26 August 2022
Session
Lipids 1
26 August 2022
Session
Latest science in primary and secondary prevention and environmental health
26 August 2022
Session
What's next to reduce cardiovascular risk?
27 August 2021
Session
ESC Geoffrey Rose Lecture in Population Sciences and Florence Nightingale Lecture in Nurse-Led Research
27 August 2021
Session
Would you give it to your grandmother? - Primary prevention in the elderly
3 September 2019

